Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsThe authors recently reported a SARS-CoV-2 human Fc-conjugated receptor-binding domain mRNA vaccine delivered via lipid nanoparticles.
[ACS Nano]
6445212 8YVM6H8R items 1 apa 0 default asc 1 162631 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-c91cdf366427c1a44b35ec34de18146b%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%228YVM6H8R%22%2C%22library%22%3A%7B%22id%22%3A6445212%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Elia%20et%20al.%22%2C%22parsedDate%22%3A%222021-05-25%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EElia%2C%20U.%2C%20Rotem%2C%20S.%2C%20Bar-Haim%2C%20E.%2C%20Ramishetti%2C%20S.%2C%20Naidu%2C%20G.%20S.%2C%20Gur%2C%20D.%2C%20Aftalion%2C%20M.%2C%20Israeli%2C%20M.%2C%20Bercovich-Kinori%2C%20A.%2C%20Alcalay%2C%20R.%2C%20Makdasi%2C%20E.%2C%20Chitlaru%2C%20T.%2C%20Rosenfeld%2C%20R.%2C%20Israely%2C%20T.%2C%20Melamed%2C%20S.%2C%20Abutbul%20Ionita%2C%20I.%2C%20Danino%2C%20D.%2C%20Peer%2C%20D.%2C%20%26amp%3B%20Cohen%2C%20O.%20%282021%29.%20Lipid%20Nanoparticle%20RBD-hFc%20mRNA%20Vaccine%20Protects%20hACE2%20Transgenic%20Mice%20against%20a%20Lethal%20SARS-CoV-2%20Infection.%20%3Ci%3ENano%20Letters%3C%5C%2Fi%3E.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1021%5C%2Facs.nanolett.1c01284%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1021%5C%2Facs.nanolett.1c01284%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445212%26amp%3Bitem_key%3D8YVM6H8R%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Lipid%20Nanoparticle%20RBD-hFc%20mRNA%20Vaccine%20Protects%20hACE2%20Transgenic%20Mice%20against%20a%20Lethal%20SARS-CoV-2%20Infection%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Uri%22%2C%22lastName%22%3A%22Elia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shahar%22%2C%22lastName%22%3A%22Rotem%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erez%22%2C%22lastName%22%3A%22Bar-Haim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Srinivas%22%2C%22lastName%22%3A%22Ramishetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gonna%20Somu%22%2C%22lastName%22%3A%22Naidu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Gur%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moshe%22%2C%22lastName%22%3A%22Aftalion%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ma%5Cu2019ayan%22%2C%22lastName%22%3A%22Israeli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adi%22%2C%22lastName%22%3A%22Bercovich-Kinori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ron%22%2C%22lastName%22%3A%22Alcalay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Efi%22%2C%22lastName%22%3A%22Makdasi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Theodor%22%2C%22lastName%22%3A%22Chitlaru%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ronit%22%2C%22lastName%22%3A%22Rosenfeld%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tomer%22%2C%22lastName%22%3A%22Israely%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sharon%22%2C%22lastName%22%3A%22Melamed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Inbal%22%2C%22lastName%22%3A%22Abutbul%20Ionita%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dganit%22%2C%22lastName%22%3A%22Danino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dan%22%2C%22lastName%22%3A%22Peer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ofer%22%2C%22lastName%22%3A%22Cohen%22%7D%5D%2C%22abstractNote%22%3A%22The%20COVID-19%20pandemic%20led%20to%20development%20of%20mRNA%20vaccines%2C%20which%20became%20a%20leading%20anti-SARS-CoV-2%20immunization%20platform.%20Preclinical%20studies%20are%20limited%20to%20infection-prone%20animals%20such%20as%20hamsters%20and%20monkeys%20in%20which%20protective%20efficacy%20of%20vaccines%20cannot%20be%20fully%20appreciated.%20We%20recently%20reported%20a%20SARS-CoV-2%20human%20Fc-conjugated%20receptor-binding%20domain%20%28RBD-hFc%29%20mRNA%20vaccine%20delivered%20via%20lipid%20nanoparticles%20%28LNPs%29.%20BALB%5C%2Fc%20mice%20demonstrated%20specific%20immunologic%20responses%20following%20RBD-hFc%20mRNA%20vaccination.%20Now%2C%20we%20evaluated%20the%20protective%20effect%20of%20this%20RBD-hFc%20mRNA%20vaccine%20by%20employing%20the%20K18%20human%20angiotensin-converting%20enzyme%202%20%28K18-hACE2%29%20mouse%20model.%20Administration%20of%20an%20RBD-hFc%20mRNA%20vaccine%20to%20K18-hACE2%20mice%20resulted%20in%20robust%20humoral%20responses%20comprising%20binding%20and%20neutralizing%20antibodies.%20In%20correlation%20with%20this%20response%2C%2070%25%20of%20vaccinated%20mice%20withstood%20a%20lethal%20SARS-CoV-2%20dose%2C%20while%20all%20control%20animals%20succumbed%20to%20infection.%20To%20the%20best%20of%20our%20knowledge%2C%20this%20is%20the%20first%20nonreplicating%20mRNA%20vaccine%20study%20reporting%20protection%20of%20K18-hACE2%20against%20a%20lethal%20SARS-CoV-2%20infection.%22%2C%22date%22%3A%222021-05-25%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1021%5C%2Facs.nanolett.1c01284%22%2C%22ISSN%22%3A%221530-6984%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1021%5C%2Facs.nanolett.1c01284%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-05-26T16%3A53%3A39Z%22%7D%7D%5D%7D
Elia, U., Rotem, S., Bar-Haim, E., Ramishetti, S., Naidu, G. S., Gur, D., Aftalion, M., Israeli, M., Bercovich-Kinori, A., Alcalay, R., Makdasi, E., Chitlaru, T., Rosenfeld, R., Israely, T., Melamed, S., Abutbul Ionita, I., Danino, D., Peer, D., & Cohen, O. (2021). Lipid Nanoparticle RBD-hFc mRNA Vaccine Protects hACE2 Transgenic Mice against a Lethal SARS-CoV-2 Infection. Nano Letters. https://doi.org/10.1021/acs.nanolett.1c01284 Cite
